COPD in 2016: some answers, more questions

Lancet Respir Med. 2016 Dec;4(12):941-943. doi: 10.1016/S2213-2600(16)30324-1. Epub 2016 Nov 22.

Authors

Wassim W Labaki¹, Carlos H Martinez¹, MeiLan K Han²

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI 48109-5360, USA.
² Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI 48109-5360, USA. Electronic address: mrking@umich.edu.

No abstract available

MeSH terms

Adrenal Cortex Hormones / therapeutic use*
Adrenergic beta-Agonists / therapeutic use*
Disease Progression
Drug Therapy, Combination
Early Diagnosis
Forced Expiratory Volume
Humans
Muscarinic Antagonists / therapeutic use*
Pulmonary Disease, Chronic Obstructive / diagnosis
Pulmonary Disease, Chronic Obstructive / drug therapy*
Pulmonary Disease, Chronic Obstructive / physiopathology
Vital Capacity

Substances

Adrenal Cortex Hormones
Adrenergic beta-Agonists
Muscarinic Antagonists

Grants and funding